A carregar...
Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
A leading strategy for developing a prophylactic HIV-1 vaccine is the elicitation of antibodies that can neutralize a large fraction of circulating HIV-1 variants. However, a major challenge that has limited the effectiveness of current vaccine candidates is the extensive global diversity of the HIV...
Na minha lista:
| Publicado no: | Viruses |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310022/ https://ncbi.nlm.nih.gov/pubmed/34372503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071296 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|